Basics |
Company: |
Passage Bio, Inc. |
IPO Date: |
February 28, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$32.42M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.30 | 4.05%
|
Avg Daily Range (30 D): |
$0.03 | 3.98%
|
Avg Daily Range (90 D): |
$0.04 | 6.26%
|
Institutional Daily Volume |
Avg Daily Volume: |
.26M |
Avg Daily Volume (30 D): |
.13M |
Avg Daily Volume (90 D): |
.38M |
Trade Size |
Avg Trade Size (Sh.): |
141 |
Avg Trade Size (Sh.) (30 D): |
438 |
Avg Trade Size (Sh.) (90 D): |
459 |
Institutional Trades |
Total Inst.Trades: |
242 |
Avg Inst. Trade: |
$1.94M |
Avg Inst. Trade (30 D): |
$1.33M |
Avg Inst. Trade (90 D): |
$1.33M |
Avg Inst. Trade Volume: |
.19M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.49M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
162.16K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.17
|
$-.31
|
$-.26
|
Diluted EPS
|
$-1.17
|
$-.31
|
$-.26
|
Revenue
|
$
|
$
|
$
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -68.8M
|
$ -19.34M
|
$ -15.99M
|
Operating Income / Loss
|
$ -74.58M
|
$ -20.7M
|
$ -17.38M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -1.29M
|
$ 7.52M
|
$ -12M
|
PE Ratio
|
|
|
|
Splits |
Jun 01, 2004:
1:20
|
|